Health
SeaStar Medical Announces Two Feature Stories on QUELIMMUNE Adoption and Patient Testimonial of Life-Saving Therapy
Cincinnati Children’s Hospital Medical Center Discusses QUELIMMUNE Therapy Adoption A Father and Patient Describe Their Real-Life Experience with the QUELIMMUNE Therapy DENVER, June 24, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing organ failure and potential loss of life announced today that the QUELIMMUNE therapy will be featured in a two-part video series t
About this update from Seastar Medical Holding Corporation
[{"type":"image","alt":"SeaStar Medical","displaySize":"","headline":null,"caption":"SeaStar Medical","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":110,"url":"https://media.zenfs.com/en/globenewswire.com/4c7240b3e0b5bc01bb2108fbeef0b4c6"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/LUjJFfXNTg2cjq9rPHCJQQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTE1NDtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/4c7240b3e0b5bc01bb2108fbeef0b4c6","width":300,"height":110}},"lazy":false},{"type":"text","content":"Cincinnati Children’s Hospital Medical Center Discusses QUELIMMUNE Therapy Adoption","length":83,"tagName":"p"},{"type":"text","content":"A Father and Patient Describe Their Real-Life Experience with the QUELIMMUNE Therapy","length":84,"tagName":"p"},{"type":"text","content":"DENVER, June 24, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing organ failure and potential loss of life announced today that the QUELIMMUNE therapy will be featured in a two-part video series that will be available on the SeaStar Medical website. The videos describe the adoption and the use of the QUELIMMUNE therapy for pediatric patients at the nationally recognized Cincinnati Children’s Hospital Medical Center and an interview with a father and his son, a pediatric patient in the ICU at Cincinnati Children’s who experienced a rapid recovery to good health following the use of the QUELIMMUNE therapy.","length":746,"tagName":"p"},{"type":"text","content":"The events will be broadcast and can be viewed as followed:","length":59,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"QUELIMMUNE Adoption: Stuart Goldstein, MD, FAAP, FNKF, at Cincinnati Children’s and Kevin Chung, MD, MACP, FCCM, Chief Medical Officer of SeaStar Medical, discuss QUELIMMUNE and its potential to reduce the destructive hyperinflammation that shuts down organs and takes lives.","length":280,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Available today, June 24, 2025, at 11:00 am Eastern Time on the Investor Relations section of Sea Star Medical’s website on the Events and Presentations page.","length":158,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":158,"olType":false}]...